Security key
14161Y200
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)
CUSIP: 14161Y200
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Class A Common Shares
- Total 13F shares
- 9,101,664
- Total 13F value
- $8,688,287
- Share change
- +1,953,121
- SEC-reported price per share
- $0.95
- Number of holders
- 41
- Value change
- +$1,769,497
- Number of buys
- 19
- Number of sells
- 25
- Shares outstanding
- 120,425,491
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
41
Top holders
10
CRDL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Cardiol Therapeutics Inc. SEC filings
Cardiol Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14161Y200
Recent filing periods:
Ownership snapshot
Top reported holders of CRDL - Cardiol Therapeutics Inc. - Class A Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Tejara Capital Ltd
Disclosed value leader
Tejara Capital Ltd
Comparable rows
0/15
Latest evidence
30 Sep 2025
13F
Highest disclosed value: $2,814,231
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Tejara Capital Ltd has the largest disclosed position value at $2.81M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Tejara Capital Ltd's linked filing trail.
Disclosed position value
Top 5
Tejara Capital Ltd
$2.81M
AdvisorShares Investments LLC
$596.4K
BANK OF AMERICA CORP /DE/
$589.6K
MARSHALL WACE, LLP
$582.4K
CITADEL ADVISORS LLC
$495.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Tejara Capital Ltd |
13F
Company
|
—
denominator unverified
|
$2,814,231
2,630,122 shares
|
— | 30 Sep 2025 |
| AdvisorShares Investments LLC |
13F
Company
|
—
denominator unverified
|
$596,405
557,388 shares
|
— | 30 Sep 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$589,627
551,053 shares
|
— | 30 Sep 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
—
denominator unverified
|
$582,419
544,317 shares
|
— | 30 Sep 2025 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$495,904
463,462 shares
|
— | 30 Sep 2025 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
—
denominator unverified
|
$344,326
321,800 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
41
Shares
9,101,664
Rows available
41
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
47
Q4 2025 holders
41
Holder diff
-6
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend